Track record
DR Kneeland Youngblood
An officer, director or large holder of 8 blank-check companies. Every role below was declared by DR Kneeland Youngblood in an SEC ownership filing.
Vehicles
8
Still live
1
Closed a deal
5 of 7
Capital involved
$2.9B
Every vehicle, newest first
- KPET Ultra Paceline CorpKPET · Director · IPO Apr 1, 2026$232MSearching
- TPG Pace Beneficial II Corp.— · Director · IPO Apr 14, 2021$400MLiquidated
- TPG Pace Solutions Corp.— · Director · IPO Apr 9, 2021$285MLiquidated
- Core Scientific, Inc./txCORZ · Director · IPO Feb 12, 2021$345MCompleted
- TPG Pace Beneficial Finance Corp.— · Director · IPO Oct 8, 2020$351MCompleted
- Nerdy Inc.NRDY · Director · IPO Oct 8, 2020$450MCompleted
- Accel Entertainment, Inc.ACEL · Director · IPO Jun 29, 2017$430MCompleted
- Pace Holdings Corp.— · Director · IPO Sep 11, 2015$450MCompleted
Compiled from Forms 3 and 3/A filed with the SEC under CIK 1137820. Roles are as declared at the time of filing and may have changed since. Nothing here is a judgement about any individual.